Airway inflammation and bronchial remodelling in toluene diisocyanate-exposed BALB/c mouse model

Scandinavian Journal of Immunology

Volumn 65, Issue 2, 2007, Pages 118-125

  Sun, L Z ^a   Elsayed, S ^a   Bronstad, A M ^a   Van Do, T ^a   Irgens, A ^a   Aardal, N P ^a   Aasen, T B ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM POTASSIUM SULFATE; AMINO ACID; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 4; OVALBUMIN; PEPTIDE; SODIUM CHLORIDE; THIOPENTAL; TOLUENE DIISOCYANATE;

AIRWAY; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BRONCHUS; CELL HYPERPLASIA; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; FEMALE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LUNG; LUNG PARENCHYMA; MOUSE; NONHUMAN; OCCUPATIONAL ASTHMA; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; SENSITIZATION; TH2 CELL;

ALUM COMPOUNDS; ANIMALS; ASTHMA; BRONCHI; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; EOSINOPHILS; FEMALE; IMMUNOGLOBULIN E; INFLAMMATION; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; NEUTROPHILS; OVALBUMIN; TH2 CELLS; TOLUENE 2,4-DIISOCYANATE;

EID: 33846606447     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2006.01882.x     Document Type: Article

References (41)

1. Pascual RM, Peters SP. Airway remodeling contributes to the progressive loss of lung function in asthma: an overview. J Allergy Clin Immunol 2005;116:477-86; quiz 487.
2. Gautrin D, Newman-Taylor AJ, Nordman H, Malo JL. Controversies in epidemiology of occupational asthma. Eur Respir J 2003;22:551-9.
3. Redlich CA, Wisnewski AV, Gordon T. Mouse models of diisocyanate asthma. Am J Respir Cell Mol Biol 2002;27:385-90.
4. Johnson VJ, Matheson JM, Luster MI. Animal models for diisocyanate asthma: answers for lingering questions. Curr Opin Allergy Clin Immunol 2004;4:105-10.
5. Scheerens H, Buckley TL, Muis TL et al. Long-term topical exposure to toluene diisocyanate in mice leads to antibody production and in vivo airway hyperresponsiveness three hours after intranasal challenge. Am J Respir Crit Care Med 1999;159:1074-80.
6. Matheson JM, Johnson VJ, Luster MI. Immune mediators in a murine model for occupational asthma: studies with toluene diisocyanate. Toxicol Sci 2005;84:99-109.
7. Raulf-Heimsoth M, Baur X. Pathomechanisms and pathophysiology of isocyanate-induced diseases - summary of present knowledge. Am J Ind Med 1998;34:137-43.
8. Wisnewski AV, Redlich CA. Recent developments in diisocyanate asthma. Curr Opin Allergy Clin Immunol 2001;1:169-75.
9. Valstar DL, Schijf MA, Nijkamp FP, Bloksma N, Henricks PA. Glutathione-conjugated toluene diisocyanate causes airway inflammation in sensitised mice. Arch Toxicol 2004;78:533-9.
10. Tee RD, Cullinan P, Welch J, Burge PS, Newman-Taylor AJ. Specific IgE to isocyanates: a useful diagnostic role in occupational asthma. J Allergy Clin Immunol 1998;101:709-15.
11. Son M, Lee M, Kim YT, Youn JK, Park H. Heterogeneity of IgE response to TDI-HSA conjugates by ELISA in toluene diisocyanate (TDI)-induced occupational asthma (OA) patients. J Korean Med Sci 1998;13:147-52.
12. Park HS, Lee SK, Kim HY, Nahm DH, Kim SS. Specific immunoglobulin E and immunoglobulin G antibodies to toluene diisocyanate-human serum albumin conjugate: useful markers for predicting long-term prognosis in toluene diisocyanate-induced asthma. Clin Exp Allergy 2002;32:551-5.
13. Nabe T, Yamauchi K, Shinjo Y et al. Delayed-type asthmatic response induced by repeated intratracheal exposure to toluene-2,4-diisocyanate in guinea pigs. Int Arch Allergy Immunol 2005;137:115-24.
14. Johnson VJ, Yucesoy B, Luster MI. Prevention of IL-1 signaling attenuates airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. J Allergy Clin Immunol 2005;116:851-8.
15. Maestrelli P, Occari P, Turato G et al. Expression of interleukin (IL)-4 and IL-5 proteins in asthma induced by toluene diisocyanate (TDI). Clin Exp Allergy 1997;27:1292-8.
16. Fabbri LM, Boschetto P, Zocca E et al. Bronchoalveolar neutrophilia during late asthmatic reactions induced by toluene diisocyanate. Am Rev Respir Dis 1987;136:36-42.
17. Sastre J, Banks DE, Lopez M, Barkman HW, Salvaggio JE. Neutrophil chemotactic activity in toluene diisocyanate (TDI)-induced asthma. J Allergy Clin Immunol 1990;85:567-72.
18. Lummus ZL, Alam R, Bernstein JA, Bernstein DI. Diisocyanate antigen-enhanced production of monocyte chemoattractant protein-1, IL-8, and tumor necrosis factor-alpha by peripheral mononuclear cells of workers with occupational asthma. J Allergy Clin Immunol 1998;102:265-74.
19. Johnsen G, Elsayed S. Antigenic and allergenic determinants of ovalbumin-III. MHC Ia-binding peptide (OA 323-339) interacts with human and rabbit specific antibodies. Mol Immunol 1990;27:821-7.
20. Ray P, Tang W, Wang P et al. Regulated overexpression of interleukin 11 in the lung. Use to dissociate development-dependent and -independent phenotypes. J Clin Invest 1997;100:2501-11.
21. Borchers MT, Crosby J, Farmer S et al. Blockade of CD49d inhibits allergic airway pathologies independent of effects on leukocyte recruitment. Am J Physiol Lung Cell Mol Physiol 2001;280:L813-21.
22. Hao M, Comier S, Wang M, Lee JJ, Nel A. Diesel exhaust particles exert acute effects on airway inflammation and function in murine allergen provocation models. J Allergy Clin Immunol 2003;112:905-14.
23. Bardana EJ. Occupational asthma and allergies. J Allerg Clin Immunol 2003;111:S530-9.
24. Cullinan P, Newman Taylor A. Asthma: environmental and occupational factors. Br Med Bull 2003;68:227-42.
25. Temelkovski J, Hogan SP, Shepherd DP, Foster PS, Kumar RK. An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 1998;53:849-56.
26. Wenzel SE, Schwartz LB, Langmack EL et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999;160:1001-8.
27. Anees W, Huggins V, Pavord ID, Robertson AS, Burge PS. Occupational asthma due to low molecular weight agents: eosinophilic and non-eosinophilic variants. Thorax 2002;57:231-6.
28. Gibson PG, Simpson JL, Saltos N. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 2001;119:1329-36.
29. Green RH, Brightling CE, Woltmann G, Parker D, Wardlaw AJ, Pavord ID. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 2002;57:875-9.
30. Tarlo SM. Occupational asthma: a valid model for adult asthma? Curr Opin Allergy Clin Immunol 2003;3:91-4.
31. Ban M, Morel G, Langonne I, Huguet N, Pepin E, Binet S. TDI can induce respiratory allergy with Th2-dominated response in mice. Toxicology 2006;218:39-47.
32. Aikawa T, Shimura S, Sasaki H, Ebina M, Takishima T. Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest 1992;101:916-21.
33. Brown MA, Hural J. Functions of IL-4 and control of its expression. Crit Rev Immunol 1997;17:1-32.
34. Vogelmeier C, Baur X, Fruhmann G. Isocyanate-induced asthma: results of inhalation tests with TDI, MDI and methacholine. Int Arch Occup Environ Health 1991;63:9-13.
35. Vanoirbeek JA, Tarkowski M, Ceuppens JL, Verbeken EK, Nemery B, Hoet PH. Respiratory response to toluene diisocyanate depends on prior frequency and concentration of dermal sensitization in mice. Toxicol Sci 2004;80:310-21.
36. Hayashi M, Higashi K, Kato H, Kaneko H. Assessment of preferential Th1 or Th2 induction by low-molecular-weight compounds using a reverse transcription-polymerase chain reaction method: comparison of two mouse strains, C57BL/6 and BALB/c. Toxicol Appl Pharmacol 2001;177:38-45.
37. Sullivan S, Bergstresser PR, Streilein JW. Analysis of dose response of trinitrochlorobenzene contact hypersensitivity induction in mice: pretreatment with cyclophosphamide reveals an optimal sensitizing dose. J Invest Dermatol 1990;94:711-6.
38. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK. Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med 1993;177:1505-9.
39. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med 1989;169:59-72.
40. Matheson JM, Lange RW, Lemus R, Karol MH, Luster MI. Importance of inflammatory and immune components in a mouse model of airway reactivity to toluene diisocyanate (TDI). Clin Exp Allergy 2001;31:1067-76.
41. Mapp CE, Saetta M, Maestrelli P et al. Mechanisms and pathology of occupational asthma. Eur Respir J 1994;7:544-54.